FDA panel recommends Pfizer vaccine for children aged 5 to 11
On Tuesday, Oct. 26, a committee from the Food and Drug Administration (FDA) recommended the Pfizer vaccine for children aged between 5 and 11 years old, a move that is likely to intensify national discourse and disagreement over whether children should receive the COVID-19 vaccine. While the vote from the panel — which voted 17…